These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2417362

  • 1. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB, Fuller BL, Falotico R, Tolman EL.
    Thromb Res; 1985 Nov 01; 40(3):401-11. PubMed ID: 2417362
    [Abstract] [Full Text] [Related]

  • 2. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM, Sloane BF, Honn KV.
    Thromb Res; 1984 Jun 01; 34(5):367-78. PubMed ID: 6377570
    [Abstract] [Full Text] [Related]

  • 3. Effects of diltiazem and verapamil on ADP-induced rabbit platelet shape change and aggregation.
    Dehpour AR, Samadian T, Akhavan MM, Meysamee F, Delfan A.
    Gen Pharmacol; 1995 Oct 01; 26(6):1295-9. PubMed ID: 7590122
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
    Beretz A, Briançon-Scheid F, Stierlé A, Corre G, Anton R, Cazenave JP.
    Biochem Pharmacol; 1986 Jan 15; 35(2):257-62. PubMed ID: 3002388
    [Abstract] [Full Text] [Related]

  • 6. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 15; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 7. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
    el Tahir KE, el-Naser MA, Ageel AM, el-Obeid HA, al-Rashood KA.
    Arch Int Pharmacodyn Ther; 1990 Apr 15; 307():162-71. PubMed ID: 2095711
    [Abstract] [Full Text] [Related]

  • 8. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J, Chopra H, Rong X, Hatfield JS, Fligiel SE, Onoda JM, Taylor JD, Honn KV.
    J Cancer Res Clin Oncol; 1992 Apr 15; 118(6):425-34. PubMed ID: 1377695
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA, Johnson PC, Smith M, Salzman EW.
    Circ Res; 1986 Jul 15; 59(1):39-42. PubMed ID: 3089642
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN, Sinha AK.
    Biochim Biophys Acta; 1989 Aug 21; 984(1):113-8. PubMed ID: 2548620
    [Abstract] [Full Text] [Related]

  • 13. Membrane activity, antioxidant, antiaggregatory and antihemolytic properties of four calcium channel blockers.
    Robak J, Duniec Z.
    Pharmacol Res Commun; 1986 Dec 21; 18(12):1107-17. PubMed ID: 3562505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME, Renzulli LA.
    Thromb Haemost; 1992 Jan 23; 67(1):131-6. PubMed ID: 1319614
    [Abstract] [Full Text] [Related]

  • 17. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
    Johnson GJ, Leis LA, Francis GS.
    Thromb Res; 1990 Jul 01; 59(1):139-48. PubMed ID: 2399526
    [Abstract] [Full Text] [Related]

  • 18. Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
    Rostagno C, Prisco D, Paniccia R, Costanzo G, Poggesi L, Boddi M, Abbate R.
    Thromb Res; 1990 Aug 01; 59(3):531-9. PubMed ID: 2237825
    [Abstract] [Full Text] [Related]

  • 19. Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism.
    Mehta JL.
    Am J Cardiol; 1985 Jan 25; 55(3):158B-164B. PubMed ID: 2982252
    [Abstract] [Full Text] [Related]

  • 20. Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
    Lippton HL, Horwitz PM, McNamara DB, Landry AZ, Kadowitz PJ.
    Prostaglandins Leukot Med; 1984 Oct 25; 16(1):121-30. PubMed ID: 6440150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.